In a 34‑year‑old woman who ovulated on cycle day 12 after letrozole induction for infertility and had intercourse on days 10, 11, 12, and 15, is it advisable to continue intercourse on day 17 of the same cycle?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

No Additional Intercourse Needed on Day 17

After ovulation on day 12 with intercourse on days 10,11,12, and 15, continuing sexual contact on day 17 is unlikely to provide additional benefit for conception in this cycle.

Understanding the Fertile Window

The fertile window in women is biologically limited to approximately 6 days ending on the day of ovulation 1. Based on fertility awareness research, the timing of the 6-day fertile window varies greatly, even among women with regular cycles, but unprotected intercourse is most likely to result in pregnancy when it occurs within the 5 days before ovulation through the day of ovulation itself 1.

Why Day 17 Is Beyond the Fertile Window

In this case:

  • Ovulation occurred on day 12 (confirmed)
  • Intercourse occurred on days 10,11,12, and 15
  • Day 17 is now 5 days post-ovulation

After ovulation, the egg remains viable for only 12-24 hours. By day 17 (5 days post-ovulation), the egg is no longer fertilizable. The intercourse that occurred on days 10,11, and 12 already provided optimal timing, as sperm can survive in the female reproductive tract for up to 5 days and were present before, during, and immediately after ovulation 1.

Optimal Timing Was Already Achieved

The patient's intercourse pattern was excellent:

  • Days 10-12 covered the immediate pre-ovulatory and ovulatory period
  • Day 15 was within 3 days post-ovulation (though likely past the fertile window)

The intercourse on days 10,11, and 12 maximized conception probability for this cycle. Additional intercourse on day 17 will not increase the chance of pregnancy from this ovulation event.

Clinical Implications

From a practical standpoint, if pregnancy has not occurred from the appropriately timed intercourse earlier in the cycle, continuing intercourse on day 17 serves no reproductive purpose for this particular cycle. The couple should await pregnancy testing approximately 2 weeks after ovulation (around day 26-28 of the cycle) 1.

Important caveat: While additional intercourse on day 17 won't improve conception chances for this cycle, there is no medical contraindication to sexual activity. The recommendation is simply that it's not necessary from a fertility optimization perspective.

Related Questions

In a 34-year-old woman who ovulated on day 12 after letrozole (Femara) induction, is it possible for another ovum to ovulate later in the same menstrual cycle?
How to initiate letrozole for ovulation induction in a female patient with suspected Polycystic Ovary Syndrome (PCOS) phenotype D, infertility, and irregular periods who has not had a menstrual cycle in the last 70 days?
What are the next steps for a 34-year-old female with infertility, currently on letrozole (letrozole is an aromatase inhibitor) induction, who had a corpus luteum on day 12 ultrasound and experienced mild bleeding on days 14 and 15?
What is the percentage chance of conception for a 34‑year‑old woman undergoing letrozole induction who ovulated on cycle day 12 and had intercourse on days 10, 11, and 12?
Is the bleeding experienced by a 34-year-old woman from day 14 onwards of her menstrual cycle, after taking Letrozole (letrozole) for ovulation induction with ovulation confirmed on day 12, likely a menstrual period or something else, given the initial spotting followed by increased bleeding?
What are the diagnostic criteria for tumor lysis syndrome (TLS) according to the Cairo‑Bishop criteria?
In primary care, after confirming a stable osteoporotic vertebral compression fracture and intact neurologic status, what is the next step in the treatment algorithm?
What is the recommended levofloxacin dosage and duration for treating uncomplicated typhoid fever in adults and children?
What are the clinical indications for a Q‑switched Nd:YAG laser (1064 nm) delivering 5 J per pulse at 10 Hz with a 7 mm spot size?
What is the appropriate treatment for erythema nodosum in a pregnant patient?
How should transaminitis be managed in a child receiving azithromycin?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.